Maria Mainou

Thessaloniki, ESYE12, Greece

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications

Clinical trials portfolio and regulatory outcomes of ixazomib in multiple myeloma: A systematic review and meta-analysis.

Clinical trials portfolio and regulatory outcomes of ixazomib in multiple myeloma: A systematic review and meta-analysis.

Journal: British journal of haematology
Published: May 08, 2026

Reporting of primary endpoint and associated spin in randomized myeloma trials.

Reporting of primary endpoint and associated spin in randomized myeloma trials.

Journal: The oncologist
Published: March 19, 2026

Successful Outcome of Acute Promyelocytic Leukemia Complicated by Bone Marrow Necrosis and Posterior Reversible Encephalopathy Syndrome, During Treatment With an All-Trans Retinoic Acid Plus Arsenic Trioxide-Based Regimen.

Successful Outcome of Acute Promyelocytic Leukemia Complicated by Bone Marrow Necrosis and Posterior Reversible Encephalopathy Syndrome, During Treatment With an All-Trans Retinoic Acid Plus Arsenic Trioxide-Based Regimen.

Journal: Cureus
Published: March 09, 2026

Temporal variability in outcomes of identical regimens across newly diagnosed myeloma trials: a systematic review.

Temporal variability in outcomes of identical regimens across newly diagnosed myeloma trials: a systematic review.

Journal: EClinicalMedicine
Published: February 06, 2026

Patients', clinicians' and research's priorities on important outcomes in multiple myeloma: A mixed-methods study.

Patients', clinicians' and research's priorities on important outcomes in multiple myeloma: A mixed-methods study.

Journal: British journal of haematology
Published: October 14, 2025

Inconsistent definitions of transplant ineligibility in multiple myeloma: A systematic review.

Inconsistent definitions of transplant ineligibility in multiple myeloma: A systematic review.

Journal: British journal of haematology
Published: September 19, 2025

Case Report: Rapid Improvement of Chronic Lymphocytic Leukemia Infiltration of the Scalp by BCL2-Inhibitor.

Case Report: Rapid Improvement of Chronic Lymphocytic Leukemia Infiltration of the Scalp by BCL2-Inhibitor.

Journal: Case reports in oncology
Published: September 12, 2025

Optimizing oncology drug development: systematic review of 22 years of myeloma randomized controlled trials.

Optimizing oncology drug development: systematic review of 22 years of myeloma randomized controlled trials.

Journal: Journal of the National Cancer Institute
Published: September 05, 2025

Optimizing oncology drug development: systematic review of 22 years of myeloma randomized controlled trials.

Optimizing oncology drug development: systematic review of 22 years of myeloma randomized controlled trials.

Journal: Journal of the National Cancer Institute
Published: September 05, 2025

Optimizing oncology drug development: systematic review of 22 years of myeloma randomized controlled trials.

Optimizing oncology drug development: systematic review of 22 years of myeloma randomized controlled trials.

Journal: Journal of the National Cancer Institute
Published: September 05, 2025

Pegcetacoplan for the treatment of warm autoimmune hemolytic anemia: a case report.

Pegcetacoplan for the treatment of warm autoimmune hemolytic anemia: a case report.

Journal: Blood cells, molecules & diseases
Published: April 07, 2025

Real-life experience of luspatercept in transfusion-dependent lower risk myelodysplastic syndrome patients.

Real-life experience of luspatercept in transfusion-dependent lower risk myelodysplastic syndrome patients.

Journal: British journal of haematology
Published: January 17, 2025
Showing 1-12 of 39

Last Updated: 09/26/2026